Kemwell Biopharma increases biologics manufacturing capacity

Date Published04/28/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Kemwell Biopharma
Parent companyRecipharm
Type of work Manufacturing
If manufacturing, is the company a contract manufacturer?Yes
Reshoring category:Foreign Direct Investment
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2021
Domestically, the work will be done:In-house
Capital investment ($):25
Country(ies) from which reshored:India
If relevant, work nearshored to:-
Product(s) reshoredbiopharma, pharmaceuticals
What domestic positive factors made reshoring more attractive?Under-utilized capacity
Find Reshoring Articles